CRISPR/Cas9-Based Modeling of <i>JAK2</i> V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents. [PDF]
Nilsri N +4 more
europepmc +1 more source
JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing. [PDF]
Mahe E +7 more
europepmc +1 more source
Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2 <sup>V617F</sup> Mutation. [PDF]
Liu Y +7 more
europepmc +1 more source
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association? [PDF]
Liu KG +6 more
europepmc +1 more source
Essential thrombocythemia during treatment of acute myeloid leukemia with JAK2 V617F mutation: A case report of a CARE-compliant article. [PDF]
Ding W +7 more
europepmc +1 more source
Frequency of Non-Type I/II <i>CALR</i> Mutations in Patients Undergoing Molecular Diagnostics for Myeloproliferative Neoplasms. [PDF]
Makarik T +7 more
europepmc +1 more source
Association Between <i>JAK2</i> V617F Somatic Mutation and Thoracic Aortic Aneurysms. [PDF]
Collins S, Zafar MA, Elefteriades JA.
europepmc +1 more source
JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis. [PDF]
Choi MY +5 more
europepmc +1 more source
JAK2 V617F mutations and thrombosis in BCR-ABL1 negative myeloproliferative neoplasms: clinical profile and hematologic insights. [PDF]
Lubis AM +3 more
europepmc +1 more source
Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges. [PDF]
Maltese T +6 more
europepmc +1 more source

